OREGON PUBLIC EMPLOYEES RETIREMENT FUND - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
OREGON PUBLIC EMPLOYEES RETIREMENT FUND ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$329,000
+16.3%
12,8570.0%0.00%0.0%
Q4 2020$283,000
+2.9%
12,857
-16.0%
0.00%0.0%
Q3 2020$275,000
-8.0%
15,300
+30.0%
0.00%0.0%
Q2 2020$299,000
-4.2%
11,773
-30.6%
0.00%
-20.0%
Q1 2020$312,000
-16.6%
16,9730.0%0.01%0.0%
Q4 2019$374,00016,9730.01%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders